Your browser doesn't support javascript.
loading
Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial.
Ruff, Christian T; Giugliano, Robert P; Braunwald, Eugene; Morrow, David A; Murphy, Sabina A; Kuder, Julia F; Deenadayalu, Naveen; Jarolim, Petr; Betcher, Joshua; Shi, Minggao; Brown, Karen; Patel, Indravadan; Mercuri, Michele; Antman, Elliott M.
Afiliação
  • Ruff CT; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: cruff@partners.org.
  • Giugliano RP; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Braunwald E; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Morrow DA; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Murphy SA; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Kuder JF; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Deenadayalu N; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Jarolim P; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Betcher J; Quintiles Inc, Research Triangle Park, NC, USA.
  • Shi M; Daiichi-Sankyo Pharma Development, Edison, NJ, USA.
  • Brown K; Daiichi-Sankyo Pharma Development, Edison, NJ, USA.
  • Patel I; Daiichi-Sankyo Pharma Development, Edison, NJ, USA.
  • Mercuri M; Daiichi-Sankyo Pharma Development, Edison, NJ, USA.
  • Antman EM; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Lancet ; 385(9984): 2288-95, 2015 Jun 06.
Article em En | MEDLINE | ID: mdl-25769361

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridinas / Fibrilação Atrial / Tiazóis / Inibidores do Fator Xa Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Revista: Lancet Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridinas / Fibrilação Atrial / Tiazóis / Inibidores do Fator Xa Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Revista: Lancet Ano de publicação: 2015 Tipo de documento: Article